Bayer in deal to search U.K. NHS data for heart drug clues

Read More

Sensyne Health Partners with Bayer to Accelerate New Treatments for Cardiovascular Disease

Read More

Bayer, Sensyne to use AI platform to accelerate CV development

Read More

Clinical AI firm Sensyne partnering with Bayer to improve cardiovascular trials

Read More

Sensyne Health, Bayer collaborate on new AI-powered treatments for heart disease

Read More

How we can place a value on healthcare data

Read More

AI firm Sensyne Health signs £5m agreement with Bayer

Read More

Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline

Read More

Sensyne Health to collaborate with Bayer in first major deal

Read More

Sensyne Health and Bayer sign collaboration agreement to accelerate cardiovascular drug development

Read More

Sensyne Health Shares Jump As Secures Development Deal With Bayer

Read More

Sensyne Health partners with Bayer to develop treatment for heart disease using AI

Read More

Bayer taps Sensyne Health AI and real world data for cardiovascular research

Read More

Bayer CV Pact Gives AI-Focused Sensyne Health Its First Big Deal Since 2018 IPO

Read More

Sensyne Health signs collaboration agreement with Bayer

Read More

Bloomberg: Bayer Makes AI Deal to Search for Heart Drug Clues in U.K. Health Data

Read More

Schrödinger Building, Oxford Science Park

Oxford Office

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

+44 (0) 330 058 1845

Contact us

For press enquiries, please contact press@sensynehealth.com